Sign in Subscribe
Stock offerings

Observe Medical ASA Strengthens Strategic Partnership with Jiangsu Hongxin Medical Technology Co. Ltd

Strategic Insights

— 1 min read

Observe Medical ASA, a Norwegian-based medical device company, has announced the strengthening of its strategic partnership with Jiangsu Hongxin Medical Technology Co. Ltd, a key manufacturing partner, through Jiangsu's subscription for 6,000,000 shares in the company. This agreement not only solidifies their collaboration but also provides a significant positive liquidity effect, freeing up capital to accelerate the commercial rollout of UnoMeter. The partnership will enable Observe Medical to focus on the development and commercialization of its medical devices, while Jiangsu will continue to provide manufacturing support.

Key Takeaways:

  • Observe Medical ASA has entered into a strategic partnership with Jiangsu Hongxin Medical Technology Co. Ltd, further solidifying their collaboration.
  • Jiangsu has subscribed for 6,000,000 shares in Observe Medical ASA, with a nominal value of NOK 0.42 per share, at a subscription price of NOK 0.50 per share.
  • The partnership will provide a significant positive liquidity effect, freeing up capital to accelerate the commercial rollout of UnoMeter.
  • The issued shares will be registered with the Norwegian Central Securities Depository Euronext Securities Oslo (VPS), but will not be tradable on Euronext Expand Oslo until the prospectus is approved by the Financial Supervisory Authority of Norway (NFSA).
  • Following the issuance of the shares, Observe Medical's share capital will be NOK 10,608,533.04, divided into 25,258,412 shares, with Jiangsu holding approximately 23.75% of the issued share capital and votes.
  • The prospectus is expected to be approved by the NFSA and published by Observe Medical at the end of Q3 2025.

Statistics:

  • 6,000,000 new shares issued to Jiangsu by Observe Medical ASA
  • Nominal value per share: NOK 0.42
  • Subscription price per share: NOK 0.50
  • Total subscription amount: NOK 3,000,000
  • Expected completion date: 4 July 2025
  • Expected registration date: Q3 2025
  • Expected trade date on Euronext Expand Oslo: upon prospectus approval and publication

Sources:

  • Observe Medical ASA news release
  • Observe Medical ASA stock exchange announcement on 11 June 2025
  • Observe Medical ASA extraordinary general meeting on 7 January 2025
  • Debt transfer agreement between Observe Medical AB and Observe Medical ASA on 27 June 2025

Read more